Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2
出版年份 2021 全文链接
标题
Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2
作者
关键词
oxaliplatin, colorectal cancer, pyruvate kinase isoenzyme M2, adenosine triphosphate, resistance, glucose, scutellarin, metabolism, overexpression
出版物
Molecular Therapy-Oncolytics
Volume 21, Issue -, Pages 87-97
出版商
Elsevier BV
发表日期
2021-03-19
DOI
10.1016/j.omto.2021.03.010
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Drug combinations: a strategy to extend the life of antibiotics in the 21st century
- (2019) Mike Tyers et al. NATURE REVIEWS MICROBIOLOGY
- PKM2, function and expression and regulation
- (2019) Ze Zhang et al. Cell and Bioscience
- PKM2, a potential target for regulating cancer
- (2018) Yu-huan Li et al. GENE
- Scutellarin Inhibits Proliferation, Invasion, and Tumorigenicity in Human Breast Cancer Cells by Regulating HIPPO-YAP Signaling Pathway
- (2017) Lengchen Hou et al. MEDICAL SCIENCE MONITOR
- Recent Therapeutic Advances in the Treatment of Colorectal Cancer
- (2015) Kristen K. Ciombor et al. Annual Review of Medicine
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PHD1 regulates p53-mediated colorectal cancer chemoresistance
- (2015) S. Deschoemaeker et al. EMBO Molecular Medicine
- Colorectal cancer
- (2015) Ernst J. Kuipers et al. Nature Reviews Disease Primers
- PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma
- (2015) Wei-Ren Liu et al. Oncotarget
- Overexpression of MicroRNA-122 Re-sensitizes 5-FU-Resistant Colon Cancer Cells to 5-FU Through the Inhibition of PKM2 In Vitro and In Vivo
- (2014) Jinxia He et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Inhibition of Girdin enhances chemosensitivity of colorectal cancer cells to oxaliplatin
- (2014) Ya-Jie Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells
- (2013) William J. Israelsen et al. CELL
- Methods of overcoming treatment resistance in colorectal cancer
- (2013) Sally Temraz et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Scutellarin inhibits the growth and invasion of human tongue squamous carcinoma through the inhibition of matrix metalloproteinase-2 and -9 and αvβ6 integrin
- (2013) HAIXIA LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- PKM2 Regulates Chromosome Segregation and Mitosis Progression of Tumor Cells
- (2013) Yuhui Jiang et al. MOLECULAR CELL
- miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase
- (2013) Yunfei Zhou et al. Molecular Oncology
- Ginsenoside Rb1 Attenuates Oxygen-Glucose Deprivation-Induced Apoptosis in SH-SY5Y Cells via Protection of Mitochondria and Inhibition of AIF and Cytochrome c Release
- (2013) Jianmin Liang et al. MOLECULES
- Long-term results with oral fluoropyrimidines and oxaliplatin-based preoperative chemoradiotherapy in patients with resectable rectal cancer. A single-institution experience
- (2012) Robert Díaz Beveridge et al. Clinical & Translational Oncology
- Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer
- (2012) Jose J. G. Marin et al. DRUG METABOLISM REVIEWS
- Targeting cancer cell mitochondria as a therapeutic approach
- (2012) Shijun Wen et al. Future Medicinal Chemistry
- Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells
- (2011) Y. Zhou et al. CANCER RESEARCH
- Understanding the metabolic basis of drug resistance
- (2011) Ubaldo E. Martinez-Outschoorn et al. CELL CYCLE
- Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo
- (2010) Varda Shoshan-Barmatz et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Synergistic drug combinations tend to improve therapeutically relevant selectivity
- (2009) Joseph Lehár et al. NATURE BIOTECHNOLOGY
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
- (2008) Jim Cassidy et al. JOURNAL OF CLINICAL ONCOLOGY
- Bcl-xL and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells
- (2008) Henning Schulze-Bergkamen et al. WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now